Jeff Auxier Invests in Gilead, Wells Fargo, Apple

- By Tiziano Frateschi

Jeff Auxier (Trades, Portfolio) is the manager of Auxier Focus Fund. He manages a portfolio composed of 152 stocks with a total value of $460 million. In the fourth and third quarters of 2016 the guru bought shares in the following stocks:


Gilead Sciences Inc. (GILD)

During the third quarter of 2016, the guru increased his stake by 60.36% and in the fourth quarter increased it by 14.53%.

Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors. During the fourth quarter total revenues were $7.3 billion, compared to $8.5 billion for the same period a year before and net income was $3.1 billion, or $2.34 per diluted share, compared to $4.7 billion, or $3.18 per diluted share, for the same quarter of 2015.

Jim Simons (Trades, Portfolio) is the largest shareholder among the gurus with 0.4% of outstanding shares followed by Pioneer Investments (Trades, Portfolio) with 0.21%, John Rogers (Trades, Portfolio) with 0.21%, T Rowe Price Equity Income Fund (Trades, Portfolio) with 0.11%, Joel Greenblatt (Trades, Portfolio) with 0.08%, Jeremy Grantham (Trades, Portfolio) with 0.07%, David Carlson (Trades, Portfolio) with 0.06% and Ken Fisher (Trades, Portfolio) with 0.03%.

Wells Fargo & Co. (WFC)

During third quarter of 2016, the investor increased his stake by 92.29% and again by 4.59% in the fourth quarter. The guru holds 0.11% of the stock's outstanding shares.

Wells Fargo is a diversified financial services company. It provides retail, corporate and commercial banking services through banking stores and offices, the internet and other distribution channels to individuals, businesses and institutions. During the last month the company announced that it had entered into an agreement with Intuit Inc. (INTU), which allows Wells Fargo customers who use financial management tools to use an innovative application-programming interface (API) when importing their bank account information.

The largest shareholder among the gurus is Warren Buffett (Trades, Portfolio) with 9.59% of outstanding shares followed by Dodge & Cox with 1.43%, Barrow, Hanley, Mewhinney & Strauss with 0.71%, Chris Davis (Trades, Portfolio) with 0.53%, PRIMECAP Management (Trades, Portfolio) with 0.37%, Fisher with 0.37%, Tom Russo (Trades, Portfolio) with 0.29% and HOTCHKIS & WILEY with 0.13%.

Apple Inc. (AAPL)

During the third quarter of 2016, the guru increased his position by 0.67%. In the fourth quarter, he again added to his position by 6.62%.

Apple designs, manufactures and markets mobile communication and media devices, personal computers and portable digital music players and sells a variety of related software, services, accessories, networking solutions and third-party digital content.

Buffett is the largest shareholder among the gurus with 1.09% of outstanding shares followed by Fisher with 0.22%, Spiros Segalas (Trades, Portfolio) with 0.21%, Pioneer Investments with 0.18%, David Einhorn (Trades, Portfolio) with 0.11% and Grantham with 0.1%.

AT&T Inc. (T)

During the third quarter of 2016, the investor increased his holding by 1.78% and again by 1.54% in the fourth quarter.

AT&T through its subsidiaries and affiliates provides wireless and wireline telecommunications services in the U.S. and internationally. The company has three reportable segments: Wireless, Wireline and Other. During the fourth quarter consolidated revenues were $41.8 billion versus $42.1 billion in the year-ago quarter, operating income was $4.2 billion versus $7.5 billion and operating income margin was 10.2% versus 17.9% in the fourth quarter of a year before.

The largest shareholder among the gurus is Barrow, Hanley, Mewhinney & Strauss with 0.28% of outstanding shares followed by PRIMECAP Management with 0.25%, Pioneer Investments with 0.13%, Richard Perry (Trades, Portfolio) with 0.1%, Mario Gabelli (Trades, Portfolio) with 0.03% and First Eagle Investment (Trades, Portfolio) with 0.02%.

Allergan PLC (AGN)

During the third quarter, the investor boosted his position by 542.86% and in the fourth quarter added another 16.15%.

Allergan is a specialty pharmaceutical company. The company is engaged in developing, manufacturing and distributing generic, brand and biosimilar products. During the last month the company agreed to acquire ZELTIQ Aesthetics Inc. (ZLTQ) for $56.50 per share, or $2.475 billion, subject to customary adjustments. This acquisition is highly complementary and strategic to Allergan

The largest shareholder among the gurus is Vanguard Health Care Fund (Trades, Portfolio) with 3.6% of outstanding shares followed by David Tepper (Trades, Portfolio) with 1.27%, John Paulson (Trades, Portfolio) with 1.06%, Seth Klarman (Trades, Portfolio) with 1.02%, Paul Singer (Trades, Portfolio) with 0.82%, John Griffin (Trades, Portfolio) with 0.46% and Segalas with 0.41%.

The Mosaic Co. (MOS)

During the third quarter, the investor increased his holding by 20.46% and in the fourth quarter by 8.62%. The guru currently holds 0.02% of the stock's outstanding shares.

Mosaic produces and markets concentrated phosphate and potash crop nutrients. It is organized into the two business segments: Phosphates and Potash. Fourth quarter net earnings of $12 million were down from $155 million in the same quarter of 2015 and net sales were $1.9 billion, down from $2.2 billion in the fourth quarter of the prior year.

Richard Snow (Trades, Portfolio) is the largest shareholder among the gurus with 0.39% of outstanding shares followed by Rogers with 0.06%, John Buckingham (Trades, Portfolio) with 0.03% and Grantham with 0.03%.

LyondellBasell Industries NV (LYB)

During the third quarter of 2016 the guru increased his stake by 14.38%. In the fourth quarter, he added to his position by 5.16%. The guru holds 0.01% of the stock's outstanding shares.

LyondellBasell Industries is a plastics, chemical and refining company. The company produces polypropylene and polypropylene compounds, propylene oxide, polyethylene, ethylene and propylene. It also provides technology licenses. Fourth-quarter income from continuing operations was $770 million compared to $797 million in the same quarter of prior year, and EBITDA was $1.40 billion compared to 1.39 billion in the fourth quarter of 2015.

The largest shareholder among the gurus is Andreas Halvorsen (Trades, Portfolio) with 0.57% of outstanding shares followed by Barrow, Hanley, Mewhinney & Strauss with 0.23%, Grantham with 0.18%, Stanley Druckenmiller (Trades, Portfolio) with 0.14%, RS Investment Management (Trades, Portfolio) with 0.08%, Pioneer Investments with 0.02%, Ray Dalio (Trades, Portfolio) with 0.02%, PRIMECAP Management with 0.02% and Manning & Napier Advisors Inc. with 0.02%.

Biogen Inc. (BIIB)

During the third quarter of 2016 the investor increased his stake by 25.85% and in the fourth quarter increased it by 11.80%. The guru holds 0.01% of the stock's outstanding shares.

Biogen is a biopharmaceutical company. The company discovers, develops, manufactures and markets therapies for neurological, autoimmune and hematologic disorders.

PRIMECAP Management is the largest shareholder among the gurus with 7.22% of outstanding shares followed by Vanguard Health Care Fund with 1.83%, Frank Sands (Trades, Portfolio) with 1.19%, Halvorsen with 0.89%, Segalas with 0.59%, Simons with 0.33% and Eric Mindich (Trades, Portfolio) with 0.19%.

Disclosure: I do not own shares of any stocks mentioned in this article.

Start a free seven-day trial of Premium Membership to GuruFocus.

This article first appeared on GuruFocus.


Advertisement